DrugPatentWatch Database Preview

Drugs in Development Information for Oprelvekin

« Back to Dashboard

Summary for Oprelvekin

US Patents	41
International Patents	457
US Patent Applications	0
WIPO Patent Applications	0
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2009-09-01)
Vendors	0

US Patents for Oprelvekin

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Oprelvekin		Compositions comprising serum albumin and p53 peptides fusion proteins	University of the Sciences of Philadelphia (Philadelphia, PA)
Oprelvekin		Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer	YALE UNIVERSITY (New Haven, CT)
Oprelvekin		Method of treating pancreatic cancer	ChemoCentryx, Inc. (Mountain View, CA)
Oprelvekin		Compositions and methods for improved delivery of hydrophobic agents	Lipocine, Inc. (Salt Lake City, UT)
Oprelvekin		Method and system for use in treating a patient with an anticoagulant to optimize therapy and prevent an adverse drug response	Dimensional Dosing Systems, Inc. (Wexford, PA)
Oprelvekin		Polysaccharides for pulmonary delivery of active agents	Momenta Pharmaceuticals, Inc. (Cambridge, MA)
Oprelvekin		Polymeric micelles for drug delivery	Intezyne Technologies, Inc. (Tampa, FL)

International Patents for Oprelvekin

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Oprelvekin	European Patent Office	3220953	2034-11-21
Oprelvekin	World Intellectual Property Organization (WIPO)	2016081897	2034-11-21
Oprelvekin	China	105407920	2033-05-03
Oprelvekin	European Patent Office	2991677	2033-05-03
Oprelvekin	Hong Kong	1222564	2033-05-03
Oprelvekin	Japan	2016529204	2033-05-03
Oprelvekin	World Intellectual Property Organization (WIPO)	2014178878	2033-05-03